Evaluation of confirmatory data following the Article 12 MRL review for imazamox

The applicant BASF SE submitted a request to the competent national authority in France to evaluate the confirmatory data that were identified for imazamox in the framework of the maximum residue level (MRL) review under Article 12 of Regulation (EC) No 396/2005 as not available. To address the data...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:EFSA J
Main Authors: Abdourahime, Himdata, Anastassiadou, Maria, Brancato, Alba, Brocca, Daniela, Carrasco Cabrera, Luis, De Lentdecker, Chloe, Ferreira, Lucien, Greco, Luna, Jarrah, Samira, Kardassi, Dimitra, Leuschner, Renata, Lostia, Alfonso, Lythgo, Christopher, Medina, Paula, Miron, Ileana, Molnar, Tunde, Nave, Stefanie, Pedersen, Ragnor, Raczyk, Marianna, Reich, Hermine, Ruocco, Silvia, Sacchi, Angela, Santos, Miguel, Stanek, Alois, Sturma, Juergen, Tarazona, Jose, Theobald, Anne, Vagenende, Benedicte, Verani, Alessia, Villamar‐Bouza, Laura
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2019
נושאים:
Reasoned Opinion
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7009030/
https://ncbi.nlm.nih.gov/pubmed/32626217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2019.5584
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים